- Urology Stents
- Pulmonology Stents
- Biliary and Pancreatic Stents
- Gastroenterology Stents
- Enteral Stents
Non-Vascular Stents Market size was valued at USD 1.11 billion in 2022 and is expected to reach USD 1.54 billion by 2029, growing at a CAGR of 4.8% from 2023-2029. Non-vascular stents are a type of stent that can be used for a variety of purposes, including esophageal, biliary, bronchial, colonic, and tracheal implantations. They're mostly used to carve a passage through the veins and arteries that transport lymph and blood. In addition, the human body has a network of ducts and capillaries that transfer fluids necessary for physiological functions throughout the body. The primary purpose of a non-vascular stent is to maintain the patency of stenotic arteries. They're also inserted into obstructed vessels to obtrude the narrowing walls of the vessel and increase fluid circulation via the artery and veins. Pulmonary stents are used to widen restricted airways and aid the breathing process in conditions such as chronic obstructive pulmonary disease, central airway obstruction, and asthma. Increasing technological and material breakthroughs are assisting in the development of particularly engineered stents for a variety of indications. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, The global Non-Vascular Stents Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Non-Vascular Stents Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Non-Vascular Stents market growth is driven by growing prevalence of chronic diseases, increased geriatric population who are more prone to lung cancer, pancreatic cancer, gallbladder cancer, colon/colorectal cancer, stroke, asthma, Chronic Obstructive Pulmonary Disease (COPD), chronic pancreatitis, prostate cancer, glaucoma. However, risk of complications in use and lower awareness about Non-Vascular Stents in developing and developed regions are expected to hamper the growth of non-vascular stents market over the forecast period
The non-vascular stents market size was valued at USD 1.11 Billion in 2022
The non vascular stents market key players are: Abbott Laboratories (U.S) Medtronic Public Limited company (U.S.) Braun Holding GmbH & Co. KG (B.Braun Melsungen) (Germany) Boston Scientific Corporation (U.S.) Terumo Corporation (Japan) Cook Medical (US) ELLA-CS (Czech Republic) Merit Medical Systems (US) Taewoong Medical (South Korea) Micro-Tech (China) I. Tech (South Korea)
The non-vascular stents market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Non-Vascular Stents Market Introduction |
2.1.Global Non-Vascular Stents Market - Taxonomy |
2.2.Global Non-Vascular Stents Market - Definitions |
2.2.1. Type |
2.2.2.Material |
2.2.3.End Users |
2.2.4.Geography |
2.2.5.Region |
3. Global Non-Vascular Stents Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Non-Vascular Stents Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Non-Vascular Stents Market By Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Urology Stents |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Pulmonology Stents |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Biliary and Pancreatic Stents |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Gastroenterology Stents |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Enteral Stents |
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Non-Vascular Stents Market By Material, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Metallic |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Non Metallic |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Non-Vascular Stents Market By End Users, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ambulatory Surgical Centers |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Cardiac Centres |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Non-Vascular Stents Market By Geography, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Latin America |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Asia Pacific |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. The Middle East and Africa |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. Global Non-Vascular Stents Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America Non-Vascular Stents Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Urology Stents |
10.1.2.Pulmonology Stents |
10.1.3.Biliary and Pancreatic Stents |
10.1.4.Gastroenterology Stents |
10.1.5.Enteral Stents |
10.2. Material Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Metallic |
10.2.2.Non Metallic |
10.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Ambulatory Surgical Centers |
10.3.3.Cardiac Centres |
10.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.North America |
10.4.2.Europe |
10.4.3.Latin America |
10.4.4.Asia Pacific |
10.4.5.The Middle East and Africa |
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe Non-Vascular Stents Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Urology Stents |
11.1.2.Pulmonology Stents |
11.1.3.Biliary and Pancreatic Stents |
11.1.4.Gastroenterology Stents |
11.1.5.Enteral Stents |
11.2. Material Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Metallic |
11.2.2.Non Metallic |
11.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Ambulatory Surgical Centers |
11.3.3.Cardiac Centres |
11.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.North America |
11.4.2.Europe |
11.4.3.Latin America |
11.4.4.Asia Pacific |
11.4.5.The Middle East and Africa |
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) Non-Vascular Stents Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Urology Stents |
12.1.2.Pulmonology Stents |
12.1.3.Biliary and Pancreatic Stents |
12.1.4.Gastroenterology Stents |
12.1.5.Enteral Stents |
12.2. Material Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Metallic |
12.2.2.Non Metallic |
12.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Ambulatory Surgical Centers |
12.3.3.Cardiac Centres |
12.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.North America |
12.4.2.Europe |
12.4.3.Latin America |
12.4.4.Asia Pacific |
12.4.5.The Middle East and Africa |
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13. Middle East and Africa (MEA) Non-Vascular Stents Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Urology Stents |
13.1.2.Pulmonology Stents |
13.1.3.Biliary and Pancreatic Stents |
13.1.4.Gastroenterology Stents |
13.1.5.Enteral Stents |
13.2. Material Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Metallic |
13.2.2.Non Metallic |
13.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Ambulatory Surgical Centers |
13.3.3.Cardiac Centres |
13.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.North America |
13.4.2.Europe |
13.4.3.Latin America |
13.4.4.Asia Pacific |
13.4.5.The Middle East and Africa |
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America Non-Vascular Stents Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Urology Stents |
14.1.2.Pulmonology Stents |
14.1.3.Biliary and Pancreatic Stents |
14.1.4.Gastroenterology Stents |
14.1.5.Enteral Stents |
14.2. Material Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Metallic |
14.2.2.Non Metallic |
14.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Hospitals |
14.3.2.Ambulatory Surgical Centers |
14.3.3.Cardiac Centres |
14.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.North America |
14.4.2.Europe |
14.4.3.Latin America |
14.4.4.Asia Pacific |
14.4.5.The Middle East and Africa |
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Abbott Laboratories (U.S) |
15.2.2.Medtronic Public Limited company (U.S.) |
15.2.3.Braun Holding GmbH & Co. KG (B.Braun Melsungen) (Germany) |
15.2.4.Boston Scientific Corporation (U.S.) |
15.2.5.Terumo Corporation (Japan) |
15.2.6.Cook Medical (US) |
15.2.7.ELLA-CS (Czech Republic) |
15.2.8.Merit Medical Systems (US) |
15.2.9.Taewoong Medical (South Korea) |
15.2.10.Micro-Tech (China) |
15.2.11.I. Tech (South Korea) |
16. Research Methodology |
17. Appendix and Abbreviations |